A Study of Virological Suppression (controlling a viral infection) for HIV-Positive Patients

Enter your info and the study team will contact you soon!
Your data is securely stored and only shared with the research team
For questions and more information about this study, please contact the team using the information below.
Study coordinator
Name - Anne Le
Email - atrle@ucdavis.edu
Phone - 832-605-6971

Logo Image
"The purpose of this study is to better understand what the best treatment method is to help HIV patients become undetectable."
Age: 18 years or older
Gender:
Any
Healthy Volunteers: No
Keywords: HIV, human immunodeficiency virus
Type: Other study, Phase 3
Target:
150 Participants
Investigator:
Description
We hope to learn more about managing patients with HIV. This includes better understanding what helps patients achieve HIV treatment goals. The goal of HIV treatment is becoming undetectable.

Currently, there are many different ways of helping a patient become undetectable. The purpose of this study will be to better understand what is the best way. This will ensure patients are being treated with the best possible care in the future.
This study requires

If you decide to participate in this research, you will be asked to do the following:

1.) Attend a visit with either a pharmacist or case manager 2.) Attend a visit with a doctor (if not seen by a doctor in more than 3 months) 3.) Labs - With your first visit with your pharmacist or case manager - At 4 to 8 weeks - At 12 to 16 weeks - At 24 to 36 weeks 4.) Phone calls with a pharmacist or case manager at least: - 2 weeks after first visit - Before next HIV medication refill - Monthly after until the end of the study 5.) Follow up visits with other healthcare providers if necessary

During the first visit with a pharmacist or case manager, we will make sure you are not having any problems taking your medicine. During the phone follow up calls, we will continue to see how you are doing with your medications. You may have follow up visits with other health care providers, such as your doctor, if we think there are other areas which they can help with. All visits will take place at CARES Community Health.

Lab tests will be completed at least three times. Lab tests can be done at a Quest near you or at CARES Community Health. These lab tests are standard of care for patients with a non-suppressed viral load. Your lab tests will require blood draws. Each lab draw requires 3 mL of blood depending on which tests you may need. This may be different for each person depending on the previous labs you have had done. Your participation in this research will end at your last set of lab tests, which will be at least 24 weeks, after your initial appointment with either a pharmacist or case manager.

If you were not to take part in this research, you would still have these lab tests done, be seen by your doctor, and may see other healthcare providers as your doctor recommends. By taking part in this study, you will have a visit with either a pharmacist or case manager who will focus only on your HIV medications. You will also receive more frequent phone follow up calls and refill reminders.

The treatment you get will be chosen by chance, like flipping a coin. Neither you nor the study doctor will choose what treatment you get. You will have an equal chance of being given each treatment.

Who can participate

Inclusion criteria:

  • Patients with a baseline viral load > 200 copies/ml
  • Patients who agree to program enrollment
  • Patients ≥ 18 years of age

Exclusion criteria:

  • Pregnant women
  • Adults unable to consent
  • Prisoners
Benefits and risks of participating
BENEFITS:

We cannot promise any benefits to you or others from your taking part in this research. However, possible benefits include support from CARES Community Health in helping you to reach HIV treatment goals, such as becoming undetectable. When you become undetectable, you improve your long term health and reduce the risk of spreading HIV.

RISKS:

There is minimal risk to participating in this study. There may be risks to your privacy. Your information will be stored in a password protected electronic folder on a secure network, which can only be accessed by people involved in this study. If your information leaves this folder, we will make sure the information cannot be traced to you. We will store your information in a safe and secure place. The files which contain your information will be destroyed at the end of this study.
Compensation
If you agree to take part in this research study, we will compensate you up to $200 dollars for reaching your health outcome goals.
Resources
Schedule
Study duration and period
We expect that you will be in this research study for a minimum of 24 weeks.
Recruitment period
From Dec. 20, 2017
Location
UC Davis Medical Center
2315 Stockton Boulevard
Sacramento, CA 95817
Research Topic
Conditions:
  • Hiv

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Sending

Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:


E-mail Preview